Format

Send to:

Choose Destination
See comment in PubMed Commons below
Cephalalgia. 2011 Feb;31(3):271-85. doi: 10.1177/0333102410381142. Epub 2010 Sep 22.

Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study.

Author information

  • 1Michigan Head-Pain and Neurological Institute, 3120 Professional Drive, Ann Arbor, MI 48104, USA. jrsaper@aol.com

Abstract

BACKGROUND:

Medically intractable chronic migraine (CM) is a disabling illness characterized by headache ≥15 days per month.

METHODS:

A multicenter, randomized, blinded, controlled feasibility study was conducted to obtain preliminary safety and efficacy data on occipital nerve stimulation (ONS) in CM. Eligible subjects received an occipital nerve block, and responders were randomized to adjustable stimulation (AS), preset stimulation (PS) or medical management (MM) groups.

RESULTS:

Seventy-five of 110 subjects were assigned to a treatment group; complete diary data were available for 66. A responder was defined as a subject who achieved a 50% or greater reduction in number of headache days per month or a three-point or greater reduction in average overall pain intensity compared with baseline. Three-month responder rates were 39% for AS, 6% for PS and 0% for MM. No unanticipated adverse device events occurred. Lead migration occurred in 12 of 51 (24%) subjects.

CONCLUSION:

The results of this feasibility study offer promise and should prompt further controlled studies of ONS in CM.

PMID:
20861241
[PubMed - indexed for MEDLINE]
PMCID:
PMC3057439
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk